Can omega 3 fatty acids improve respiratory outcomes in preterm infants?

Not Applicable

Completed

• Conditions: Preterm infants; Respiratory - Other respiratory disorders / diseases; Bronchopulmonary dysplasia; Reproductive Health and Childbirth - Complications of newborn

• Registration Number: ACTRN12612000503820
• Lead Sponsor: South Australian Health and Medical Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-09
• Study Completion: 2022-05-22
• Last Update Posted: 8 May 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1273

Inclusion Criteria

Born at less than 29 weeks gestational age
Within 3 days of commencing enteral feeds
Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the infant’s behalf

Exclusion Criteria

Infants who have a major congenital or chromosomal abnormality will be excluded from the study
Women providing breast milk who are taking supplements providing >250 mg DHA per day and do not wish to stop taking supplements.
Infants participating in another fatty acid study.
Infants receiving intravenous lipid emulsions containing fish oil given as early lipid parenteral nutrition support.

Study & Design

• Study Type: Interventional
• Study Design: Not specified